Selected research
Market Structure
Global Ziprasidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Ziprasidone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Ziprasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Ziprasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ziprasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Ziprasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ziprasidone include Apotex, Aurobindo, Dr. Reddy's Laboratories, Lupin Pharmaceuticals, Macleods Pharmaceuticals, Wockhardt, Zydus Pharmaceuticals, Pfizer and Mylan Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Ziprasidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Ziprasidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Ziprasidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ziprasidone market size, projected growth trends, production technologies, key applications, and end-use industries.
Ziprasidone Segment by Company
Apotex
Aurobindo
Dr. Reddy's Laboratories
Lupin Pharmaceuticals
Macleods Pharmaceuticals
Wockhardt
Zydus Pharmaceuticals
Pfizer
Mylan Pharmaceuticals
Sandoz
Ziprasidone Segment by Type
Oral Capsule
Injection
Ziprasidone Segment by Application
Hospital
Drug Store
Ziprasidone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ziprasidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ziprasidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ziprasidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Ziprasidone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ziprasidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ziprasidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Ziprasidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Capsule
- Injection
Applications
- Hospital
- Drug Store
Companies covered
- Apotex
- Aurobindo
- Dr. Reddy's Laboratories
- Lupin Pharmaceuticals
- Macleods Pharmaceuticals
- Wockhardt
- Zydus Pharmaceuticals
- Pfizer
- Mylan Pharmaceuticals
- Sandoz
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Ziprasidone Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Ziprasidone Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Ziprasidone Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Ziprasidone Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Ziprasidone Market Dynamics
- 2.1 Ziprasidone Industry Trends
- 2.2 Ziprasidone Industry Drivers
- 2.3 Ziprasidone Industry Opportunities and Challenges
- 2.4 Ziprasidone Industry Restraints
3 Ziprasidone Market by Manufacturers
- 3.1 Global Ziprasidone Revenue by Manufacturers (2021-2026)
- 3.2 Global Ziprasidone Sales by Manufacturers (2021-2026)
- 3.3 Global Ziprasidone Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Ziprasidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ziprasidone Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Ziprasidone Manufacturers, Product Type & Application
- 3.7 Global Ziprasidone Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ziprasidone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ziprasidone Players Market Share by Revenue in 2025
- 3.8.3 2025 Ziprasidone Tier 1, Tier 2, and Tier 3
4 Ziprasidone Market by Type
- 4.1 Ziprasidone Type Introduction
- 4.1.1 Oral Capsule
- 4.1.2 Injection
- 4.2 Global Ziprasidone Sales by Type
- 4.2.1 Global Ziprasidone Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Ziprasidone Sales by Type (2021-2032)
- 4.2.3 Global Ziprasidone Sales Market Share by Type (2021-2032)
- 4.3 Global Ziprasidone Revenue by Type
- 4.3.1 Global Ziprasidone Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Ziprasidone Revenue by Type (2021-2032)
- 4.3.3 Global Ziprasidone Revenue Market Share by Type (2021-2032)
5 Ziprasidone Market by Application
- 5.1 Ziprasidone Application Introduction
- 5.1.1 Hospital
- 5.1.2 Drug Store
- 5.2 Global Ziprasidone Sales by Application
- 5.2.1 Global Ziprasidone Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Ziprasidone Sales by Application (2021-2032)
- 5.2.3 Global Ziprasidone Sales Market Share by Application (2021-2032)
- 5.3 Global Ziprasidone Revenue by Application
- 5.3.1 Global Ziprasidone Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Ziprasidone Revenue by Application (2021-2032)
- 5.3.3 Global Ziprasidone Revenue Market Share by Application (2021-2032)
6 Global Ziprasidone Sales by Region
- 6.1 Global Ziprasidone Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Ziprasidone Sales by Region (2021-2032)
- 6.2.1 Global Ziprasidone Sales by Region (2021-2026)
- 6.2.2 Global Ziprasidone Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Ziprasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Ziprasidone Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Ziprasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Ziprasidone Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Ziprasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Ziprasidone Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Ziprasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Ziprasidone Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Ziprasidone Revenue by Region
- 7.1 Global Ziprasidone Revenue by Region
- 7.1.1 Global Ziprasidone Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Ziprasidone Revenue by Region (2021-2026)
- 7.1.3 Global Ziprasidone Revenue by Region (2027-2032)
- 7.1.4 Global Ziprasidone Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Ziprasidone Revenue (2021-2032)
- 7.2.2 North America Ziprasidone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Ziprasidone Revenue (2021-2032)
- 7.3.2 Europe Ziprasidone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Ziprasidone Revenue (2021-2032)
- 7.4.2 Asia-Pacific Ziprasidone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Ziprasidone Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Ziprasidone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Apotex
- 8.1.1 Apotex Company Information
- 8.1.2 Apotex Business Overview
- 8.1.3 Apotex Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Apotex Ziprasidone Product Portfolio
- 8.1.5 Apotex Recent Developments
- 8.2 Aurobindo
- 8.2.1 Aurobindo Company Information
- 8.2.2 Aurobindo Business Overview
- 8.2.3 Aurobindo Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Aurobindo Ziprasidone Product Portfolio
- 8.2.5 Aurobindo Recent Developments
- 8.3 Dr. Reddy's Laboratories
- 8.3.1 Dr. Reddy's Laboratories Company Information
- 8.3.2 Dr. Reddy's Laboratories Business Overview
- 8.3.3 Dr. Reddy's Laboratories Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Dr. Reddy's Laboratories Ziprasidone Product Portfolio
- 8.3.5 Dr. Reddy's Laboratories Recent Developments
- 8.4 Lupin Pharmaceuticals
- 8.4.1 Lupin Pharmaceuticals Company Information
- 8.4.2 Lupin Pharmaceuticals Business Overview
- 8.4.3 Lupin Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Lupin Pharmaceuticals Ziprasidone Product Portfolio
- 8.4.5 Lupin Pharmaceuticals Recent Developments
- 8.5 Macleods Pharmaceuticals
- 8.5.1 Macleods Pharmaceuticals Company Information
- 8.5.2 Macleods Pharmaceuticals Business Overview
- 8.5.3 Macleods Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Macleods Pharmaceuticals Ziprasidone Product Portfolio
- 8.5.5 Macleods Pharmaceuticals Recent Developments
- 8.6 Wockhardt
- 8.6.1 Wockhardt Company Information
- 8.6.2 Wockhardt Business Overview
- 8.6.3 Wockhardt Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Wockhardt Ziprasidone Product Portfolio
- 8.6.5 Wockhardt Recent Developments
- 8.7 Zydus Pharmaceuticals
- 8.7.1 Zydus Pharmaceuticals Company Information
- 8.7.2 Zydus Pharmaceuticals Business Overview
- 8.7.3 Zydus Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Zydus Pharmaceuticals Ziprasidone Product Portfolio
- 8.7.5 Zydus Pharmaceuticals Recent Developments
- 8.8 Pfizer
- 8.8.1 Pfizer Company Information
- 8.8.2 Pfizer Business Overview
- 8.8.3 Pfizer Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Pfizer Ziprasidone Product Portfolio
- 8.8.5 Pfizer Recent Developments
- 8.9 Mylan Pharmaceuticals
- 8.9.1 Mylan Pharmaceuticals Company Information
- 8.9.2 Mylan Pharmaceuticals Business Overview
- 8.9.3 Mylan Pharmaceuticals Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Mylan Pharmaceuticals Ziprasidone Product Portfolio
- 8.9.5 Mylan Pharmaceuticals Recent Developments
- 8.10 Sandoz
- 8.10.1 Sandoz Company Information
- 8.10.2 Sandoz Business Overview
- 8.10.3 Sandoz Ziprasidone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sandoz Ziprasidone Product Portfolio
- 8.10.5 Sandoz Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Ziprasidone Value Chain Analysis
- 9.1.1 Ziprasidone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Ziprasidone Production Mode & Process
- 9.2 Ziprasidone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Ziprasidone Distributors
- 9.2.3 Ziprasidone Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst